Company news
DocMorris Ltd news in 2025
DocMorris Ltd's news releases, calls and decks from 2025, newest first.
Swiss stocks - Factors to watch on November 14
November 14, 2025
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026
November 13, 2025
Docmorris AG Convertible And Delta Placing Final Delta Size Was C. 1.2m Shs / C. CHF 6.6m, Says Bookrunner
October 22, 2025
Bookrunner Says DocMorris AG Delta Placing Orders Below CHF 5.45 Per Share Risk Missing
October 21, 2025
Docmorris AG - Docmorris Increased Its External Revenue[1] By 9.5 Per Cent[2] To CHF 854.3 Million In First Nine Months 2025
October 16, 2025
DOCM: Rx and TeleClinic growth, margin gains, and robust funding support a positive 2025 outlook
August 19, 2025
DocMorris AG: Federal Court of Justice confirms admissibility of prescription bonuses
July 17, 2025
gematik extends DocMorris CardLink approval until January 2027
July 15, 2025
Baader Helvea cuts Docmorris to 'reduce', awaits capital increase amid weaker guidance
April 17, 2025
Aixtron, Bayer, Cerillion
April 15, 2025
DOCM: Strong Rx and TeleClinic growth, fully underwritten CHF 200m raise, EBITDA break-even in 2026
April 10, 2025
DOCM: Revenue up 7%, non-Rx profitable, Teleclinic doubled, CHF 200M raise planned for Rx growth
March 13, 2025
Calls in 2025
Decks in 2025
- H1 2025 Earnings Presentation
Earnings · 30 slides · Aug 19, 2025
- FY2024 Earnings Presentation
Earnings · 31 slides · Mar 13, 2025